Literature DB >> 12783262

Therapeutic strategies and management of desmoplastic infantile ganglioglioma: two case reports and literature overview.

Heidi Bächli1, Pierino Avoledo, Otmar Gratzl, Marcus Tolnay.   

Abstract

INTRODUCTION: Desmoplastic infantile gangliogliomas (DIG) are rare cerebral glioneural tumors usually occurring in early childhood. DIGs are generally benign although rare cases with poor outcome are known. Total resection, if possible, is the treatment of choice, without further adjuvant therapy. After incomplete resection, adjuvant chemo-and/or radiotherapy is generally applied, despite the potential negative side effects in such young patients. CASE REPORTS: We describe two girls with DIG, one who twice underwent subtotal resection at 3 and 5 months, the other who underwent total resection at 2 years. Neither had adjuvant therapy and there was no tumor recurrence.
CONCLUSIONS: Our own experience and a review of the literature suggest that in most DIGs adjuvant therapy is not justified even after incomplete resection. After tumor recurrence a second surgical intervention should be considered instead of adjuvant therapy. An exception may be made for rare, deep-seated DIGs, which are more aggressive and have a poorer outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783262     DOI: 10.1007/s00381-003-0754-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  16 in total

Review 1.  Desmoplastic infantile astrocytoma with metastases at presentation.

Authors:  S N Setty; D C Miller; L Camras; F Charbel; M L Schmidt
Journal:  Mod Pathol       Date:  1997-09       Impact factor: 7.842

2.  High amino acid uptake in a low-grade desmoplastic infantile ganglioglioma in a 14-year-old patient.

Authors:  B Woesler; T Kuwert; G Kurlemann; C Morgenroth; S Probst-Cousin; H Lerch; F Gullotta; H Wassmann; O Schober
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

3.  Desmoplastic infantile ganglioglioma--clinicopathological and immunohistochemical study of four cases.

Authors:  Pritilata Rout; Vani Santosh; Anita Mahadevan; V R Sastry Kolluri; T C Yasha; S K Shankar
Journal:  Childs Nerv Syst       Date:  2002-08-22       Impact factor: 1.475

4.  Desmoplastic non-infantile ganglioglioma.

Authors:  S Galatioto; F Gullotta
Journal:  J Neurosurg Sci       Date:  1996 Sep-Dec       Impact factor: 2.279

5.  Mixed conventional and desmoplastic infantile ganglioglioma: an autopsied case with 6-year follow-up.

Authors:  T Komori; B W Scheithauer; J E Parisi; J Watterson; J R Priest
Journal:  Mod Pathol       Date:  2001-07       Impact factor: 7.842

6.  The management of desmoplastic neuroepithelial tumours in childhood.

Authors:  C Mallucci; A Lellouch-Tubiana; C Salazar; G Cinalli; D Renier; C Sainte-Rose; A Pierre-Kahn; M Zerah
Journal:  Childs Nerv Syst       Date:  2000-01       Impact factor: 1.475

7.  Desmoplastic non-infantile ganglioglioma. Case report.

Authors:  A Marti; B Almostarchid; M Maher; A Saidi
Journal:  J Neurosurg Sci       Date:  2000-09       Impact factor: 2.279

Review 8.  Desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy.

Authors:  S R VandenBerg
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

9.  Desmoplastic cerebral astrocytomas of infancy: a histopathologic, immunohistochemical, ultrastructural, and molecular genetic study.

Authors:  D N Louis; A von Deimling; G R Dickersin; E C Dooling; B R Seizinger
Journal:  Hum Pathol       Date:  1992-12       Impact factor: 3.466

10.  Desmoplastic infantile astrocytoma and ganglioglioma: a search for genomic characteristics.

Authors:  Johan M Kros; Ernst J Delwel; T H Rob de Jong; Herve L J Tanghe; Peter R W A van Run; Kees Vissers; Janneke C Alers
Journal:  Acta Neuropathol       Date:  2002-03-29       Impact factor: 17.088

View more
  7 in total

Review 1.  Desmoplastic infantile and non-infantile ganglioglioma. Review of the literature.

Authors:  Miguel Gelabert-Gonzalez; Ramón Serramito-García; Andrea Arcos-Algaba
Journal:  Neurosurg Rev       Date:  2011-01-19       Impact factor: 3.042

2.  Desmoplastic infantile astrocytoma: recurrence with malignant transformation into glioblastoma: a case report.

Authors:  Ji Hoon Phi; Eun Jung Koh; Seung-Ki Kim; Sung-Hye Park; Byung-Kyu Cho; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2011-09-25       Impact factor: 1.475

3.  Strong desmin expression in a congenital desmoplastic infantile ganglioglioma mimicking pleomorphic rhadomyosarcoma: a case report including ultrastructural and cytogenetic evaluation and review of the literature.

Authors:  Sarah Alghamdi; Amilcar Castellano-Sanchez; Carole Brathwaite; Taiyo Shimizu; Ziad Khatib; Sanjiv Bhatia
Journal:  Childs Nerv Syst       Date:  2012-08-17       Impact factor: 1.475

4.  Desmoplastic infantile astrocytoma and ganglioglioma: a series of 12 patients treated at a single institution.

Authors:  Alessia Imperato; Pietro Spennato; Federica Mazio; Esperanza Arcas; Onur Ozgural; Lucia Quaglietta; Maria Elena Errico; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2021-01-28       Impact factor: 1.475

5.  Predictors of mortality and tumor recurrence in desmoplastic infantile ganglioglioma and astrocytoma-and individual participant data meta-analysis (IPDMA).

Authors:  Shelly Wang; Matthew Z Sun; I Joshua Abecassis; Alexander G Weil; George M Ibrahim; Aria Fallah; Chibawanye Ene; Sarah E S Leary; Bonnie L Cole; Christina M Lockwood; James M Olson; J Russell Geyer; Richard G Ellenbogen; Jeffrey G Ojemann; Anthony C Wang
Journal:  J Neurooncol       Date:  2021-10-06       Impact factor: 4.506

Review 6.  Supratentorial tumors typical of the infantile age: desmoplastic infantile ganglioglioma (DIG) and astrocytoma (DIA). A review.

Authors:  F Bianchi; G Tamburrini; L Massimi; M Caldarelli
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

Review 7.  Pediatric Low-Grade Gliomas.

Authors:  Kelly L Collins; Ian F Pollack
Journal:  Cancers (Basel)       Date:  2020-05-04       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.